Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel vs Mitoxantrone in Metastatic Prostate Cancer
NCT00417079Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2007
- Primary completion
- Sep 2009
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of cabazitaxel ginsenoside liposome injection in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Sanofi. Started Jan 2007; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT00417079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417079.